BU-NOT-SET

CONTACT US
Modified release fixed dose combination product with two poorly soluble drug substances
  • Drug product
pellets
Case study
Patient centricity during drug development and commercialisation
  • Drug product
Eyes
Insight
10 considerations to kick-start your drug development journey
  • Drug product
Eyes
Insight
Guidance for start-ups on drug development
  • Drug product
Eyes
Insight
Drug development for start-ups
  • Drug product
  • Drug substance
Test tubes
White paper
Optimising environmental sustainability
  • Sustainability
Eyes
Insight
Adapting to deal with the COVID-19 pandemic
  • Industry trends
Eyes
Insight
On Drug Delivery – Sustainability Q&A
  • Sustainability
Eyes
Insight
Optimising analytical chemistry to improve speed to market
  • Analytical chemistry
Man lab
Insight
Insight
  • Drug product
  • Manufacturing
Using blow-fill-seal technology for biologic and vaccine delivery
Webinar
Webinar: Understanding the benefits of blow-fill-seal unidose for ophthalmics, as an alternative to glass vials
Insight
  • Industry trends
  • Manufacturing
A leading global CDMO, renowned for its reliable & on-time offerings
Insight
  • Biologics
Navigating challenges in progressing breakthrough RNA therapeutics
Report
  • Sustainability
Sustainability report 2023
Insight
  • Industry trends
  • Manufacturing
Navigating pre-filled syringe filling complexities
Insight
  • Industry trends
  • Manufacturing
New product introduction: key to getting innovations from pilot to product
Case study
  • Drug product
Tackling antimicrobial resistance
Insight
  • Biologics
A new centre for continuous mRNA manufacturing